Pyrls LinkedIn · Jun 2026
Company announced a major refresh of its NAPLEX Virtual Testing Center with 1,000+ practice questions, Practice Mode, updated mock exams, timing controls, and detailed competency reports.
Modern medical reference app for healthcare providers
Company research
Public company, workplace, funding, and market signals
Updated Jul 29, 2026
Overview
Pyrls is a Minneapolis-based healthcare SaaS company that makes drug information easy for clinicians and student clinicians through a modern web, mobile, and browser-extension reference product. The company positions itself as a practical, evidence-based drug-information platform with a free tier and paid Pro and organization offerings.
Primary product
Drug information reference platform for clinicians (web app, mobile app, and browser extension)
Founded
2020
Headquarters
Minneapolis, Minnesota, United States
Team size
11-50 employees
Industry
Hospitals and Health Care
Sub-industry
Healthcare IT / drug information software
Offices
401 1st Ave NE Unit 725, Minneapolis, Minnesota 55111, United States
Business model
freemium SaaS
subscription SaaS
enterprise/org licensing
Funding
Stage
pre-seed
Total raised
$500K
Latest round
Pre-Seed · Mar 2022
Latest amount
$500K
Mar 2022 · Y Combinator
People & investors
Investors
Work & culture
Public materials emphasize simplicity, practical clinical utility, and clinician-curated evidence-based content; no dedicated public employee-culture page was found.
Product & market
Pricing
Freemium subscription SaaS with a free tier, Pyrls Pro paid subscriptions, and organization accounts/add-ons.
Differentiators
- —Free forever tier
- —800+ general drug summaries
- —50+ pharmacotherapy charts
- —drug interaction checker in Pro
- —mobile app, website, and browser extension
- —clinician-curated evidence-based content
- —organization accounts with analytics, custom content, and SSO
- —NAPLEX practice/testing center
Technology
Next.js
React
Plausible
PostHog
Stripe
Google Cloud DNS
Google Analytics (Universal)
Google Fonts
Typekit
npm CDN
Customers
pharmacists
clinicians
student clinicians
healthcare providers
health systems
pharmacies
medical practices
universities
remote clinical teams
Competitors
Epocrates
Medscape
Lexidrug
UpToDate
DynaMed
AccuRx
Seegnal
MedAware
Scale & contact
Estimated revenue
about $500K (2024 estimate)
Estimated monthly visits
28.7K
Traffic estimate as of Jul 2026
Latest news
Pyrls LinkedIn · Jun 2026
Company shared a drug-update post about the FDA approval of an every-eight-week maintenance dosing regimen for EBGLYSS, reflecting the product's ongoing clinical-content publishing cadence.
Pyrls LinkedIn · May 2026
Company announced a new dyslipidemia pharmacotherapy review and chart in the app and on pyrls.com.
Pyrls LinkedIn · Dec 2025
Company post said Richard Waithe was stepping into an expanded role to lead enterprise growth and operations, signaling a push into go-to-market and enterprise partnerships.
Business Wire · Dec 2025
PQS (an Innovaccer company) announced an integration of Pyrls into EQUIPP Copilot to embed drug-information tools, counseling points, summaries, interaction screening, and other clinical features directly into pharmacist workflow.
Jobs and careers at Pyrls
0 jobs at Pyrls
No open positions
Check back later for new openings